Low-dose Rituximab and High-dose Dexamethasone as First Line Treatment for ITP

Clinical trial NCT01107951 · COMPLETED

Trial details

NCT number: NCT01107951
Sponsor: Hospital Universitario Dr. Jose E. Gonzalez
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Immune Thrombocytopenic Purpura

Start date: 2010-04-01
Primary completion: 2010-04-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.